Earmarked Funds For Premarket Review Supported By Device Associations
This article was originally published in The Gray Sheet
Senate and House conferees should retain the $7 mil. and 45 FTEs earmarked by the Senate version of the FY 2000 agriculture appropriations bill (S 1233) for medical device reviews, the Health Industry Manufacturers Association urges in a Sept. 13 letter to the Senate Appropriations Committee.
You may also be interested in...
A Democratic amendment contained in the Senate agriculture appropriations bill (S 1233) for fiscal year 2000 directs FDA's Center for Devices and Radiological Health to allocate $1 mil. of its budget for overseeing the practice of medical device reprocessing. The legislation cleared the chamber by voice vote on Aug. 4.
FDA Commissioner Jane Henney's appointment of David Feigal, Jr., MD/MPH, to head the Center for Devices and Radiological Health once again returns industry to the position of determining whether a new device center director views FDA's regulation of devices in a different light than drugs and biologics.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.